🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David P. Steensma

Office of Chief Medical Examiner

ORCID: 0000-0001-5130-9284

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes”.

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms

Blood Advances(2019)10.1182/bloodadvances.2019000090

N/A

0.631DataRank · unranked

66 citations

Caleb Ho, Ryan N. Ptashkin, Sam Sadigh, Adam Bagg, Julia T. Geyer +11 more

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes

American Journal of Hematology(2023)10.1002/ajh.27161

N/A

0.587DataRank · unranked

49 citations

Jordi Esteve, Kimmo Porkka, Steven Knapper, Elie Traer, Sebastian Scholl +22 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias

Nature Immunology(2021)10.1038/s41590-021-00895-4

N/A

0.470DataRank · unranked

22 citations

Shrestha Ghosh, Samuel A. Myers, Michael S. Cuoco, Meromit Singer, Steven A. Carr +8 more

Practical Recommendations for Hypomethylating Agent Therapy of Patients With Myelodysplastic Syndromes

Hematology/Oncology Clinics of North America(2010)10.1016/j.hoc.2010.02.012

N/A

0.457DataRank · unranked

20 citations

Richard M. Stone, David P. Steensma

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

American Journal of Hematology(2020)10.1002/ajh.25853

N/A

0DataRank · unranked

10 citations

Terra L. Lasho, Eric Padron, Kristen McCullough, Aref Al‐Kali, Ayalew Tefferi +6 more

Patients with haematological malignancies should not have to choose between transfusions and hospice care

The Lancet Haematology(2020)10.1016/s2352-3026(20)30042-9

N/A

0DataRank · unranked

26 citations

David P. Steensma, Oreofe O. Odejide

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias

Nature Immunology(2021)10.1038/s41590-021-01031-y

N/A

0DataRank · unranked

0 citations

Shrestha Ghosh, Samuel A. Myers, Michael S. Cuoco, Meromit Singer, Steven A. Carr +8 more